Huang Michael F.
CIK 2019992 · Sr. VP of Clinical Development · last filed 2026-05-18
Huang Michael F. is a Sr. VP of Clinical Development who has filed 6 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for SLNO, was dated May 18, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
6
-$1.01M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLNO | Sr. VP of Clinical Development | 0 | $53.01 | $0 | -$1.01M | 6 | 2026-05-18 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | SLNO | Disp (D) | −39,823 | $0 | EDGAR |
| 2026-01-23 | SLNO | Grant (A) | +10,400 | $0 | EDGAR |
| 2025-12-17 | SLNO | Tax (F) | −812 | -$40.6K | EDGAR |
| 2025-03-31 | SLNO | Mixed | −4,583 | -$794.3K | EDGAR |
| 2025-01-23 | SLNO | Grant (A) | +6,400 | $0 | EDGAR |
| 2024-07-19 | SLNO | Grant (A) | +35,000 | $0 | EDGAR |